Cheah, C., Spurgeon, S., Yoon, S., Boutin, M., Barca, E. G., Bouabdallah, K., John, E., Krautloher, T., Otero, V., Kahl, B. (2025). Analysis of predictive factors for POD24 in patients with previously untreated mantle cell lymphoma receiving bendamustine-rituximab with or without acalabrutinib in the phase 3 ECHO trial. Blood. https://doi.org/10.1182/blood-2025-3578